Savara (SVRA) Share-based Compensation (2010 - 2026)
Savara's Share-based Compensation was $7.77 million in Q2 2026, up 190.9% from $2.67 million a year earlier but down 27.6% from the prior quarter.
Savara (SVRA) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Savara's Share-based Compensation was $27.27 million through Jun 30, 2026, up 146.9% year-over-year; for FY2025, it came in at $14.42 million, up 46.3% from FY2024.
- Share-based Compensation has now increased for three consecutive years, with a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $9.86 million in FY2024 (+136.0%), $4.18 million in FY2023 (+104.7%), $2.04 million in FY2022 (-37.4%) and $3.26 million in FY2021 (-36.2%).
- Quarterly Share-based Compensation has moved between $450,000 (Q3 2022) and $10.73 million (Q1 2026) over five years.
- Compared with a year earlier, Share-based Compensation has increased for 14 straight quarters, with growth averaging 110.9% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q1 2026 (growth of 260.9%); the worst was Q3 2021 (a decline of 64.3%).
- Per Business Quant data, SVRA's Share-based Compensation in the three quarters before Q2 2026 was $10.73 million (Q1 2026), $5.36 million (Q4 2025) and $3.43 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Savara | 1.04 Bn | 1.04 Bn | - | 7.77 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.77 Mn |
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | 5.36 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 995,000.00 |
| Jun 30, 2023 | 958,000.00 |
| Mar 31, 2023 | 864,000.00 |
| Dec 31, 2022 | 561,000.00 |
| Sep 30, 2022 | 450,000.00 |
| Jun 30, 2022 | 456,000.00 |
| Mar 31, 2022 | 574,000.00 |
| Dec 31, 2021 | 853,000.00 |
| Sep 30, 2021 | 690,000.00 |
Savara Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();